Skip to search formSkip to main contentSkip to account menu

JTT 608

Known as: JTT-608 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • 2017
  • Corpus ID: 55583882
Diabetes Research Foundation, “Diabetes and Your Eyesight.” printed from http://www.glaucoma.org/learn? diabetes and yo. html, 2… 
2005
2005
Aim:  Chronic glycaemic control, in particular, the control of postprandial hyperglycaemia, is essential for preventing the… 
2001
2001
Insulin secretion from MIN6 cells (a pancreatic beta-cell line) induced by high glucose (greater than 16.8 mM) was potentiated by… 
2001
2001
A new nonsulfonylurea oral hypoglycemic agent, JTT-608, has been reported to stimulate insulin release at elevated, but not low… 
2000
2000
We examined the effects of the novel hypoglycaemic agent JTT‐608 [trans‐4‐(4‐methylcyclohexyl)‐4‐oxobutyric acid] on insulin… 
1999
1999
We investigated the pharmacological effects of a new antidiabetic agent, JTT‐608, in comparison with the sulphonylurea… 
1998
1998
During an investigation of drugs for improving the beta-cell response to glucose, we found that 4-cyclohexyl-4-oxobutyric acid…